结果所有患者都有明显血液学反应，临床症状有不同程度的改善，部分患者获得缓解。
RESULTS: All the patients have significant hematological response, clinical symptoms have different degrees of improvement, some patients were eased.
主要的不良反应为血液学毒性，表现为白细胞下降、中性粒细胞下降、血小板下降和血红蛋白下降，其次为消化道症状。
The main adverse reactions were hematologic toxicity. The manifestations were: WBC, neutrophile granulocyte, blood platelet and hemoglobin all decreased, then was digestive canal symptoms.
主要不良反应为输注相关的不良反应（32 % ）和化疗相关的血液学毒副反应（2 0 % ）。
The regimen could be well tolerated, and the major adverse reactions were infusion-related response (32%) and hematological toxicities (20%).
应用推荐